|
|
||||||||


Departments of
* Neurobiology and
Immunology, Weizmann Institute of Science, Rehovot, Israel
The resistance of rats or mice to glutamate-induced toxicity depends on their ability to spontaneously manifest a T cell-dependent response to the insult. Survival of retinal ganglion cells (RGCs) exposed to glutamate in BALB/c SCID mice (a strain relatively resistant to glutamate toxicity) was significantly worse than in the wild type. In the susceptible C57BL/6J mouse strain, however, significantly more RGCs survived among SCID mutants than in the matched wild type. RGC survival in the SCID mutants of the two strains was similar. These results suggest 1) that immunodeficiency might be an advantage in strains incapable of spontaneously manifesting protective T cell-dependent immunity and 2) that B cells might be destructive in such cases. After exposure of RGCs to toxic glutamate concentrations in three variants of B cell-deficient C57BL/6J mice, namely muMT-/- (B cell knockout mice) and Ii-/- mice reconstituted with transgenically expressed low levels of Ii p31 isoforms (p31 mice) or Ii p41 isoforms (p41 mice), significantly more RGCs survived in these mice than in the wild type. The improved survival was diminished by replenishment of the B cell-deficient mice with B cells derived from the wild type. It thus seems that B cells have an adverse effect on neuronal recovery after injury, at least in a strain that is unable to spontaneously manifest a T cell-dependent protective mechanism. These findings have clear implications for the design of immune-based therapies for CNS injury.
This article has been cited by other articles:
![]() |
S. Rossignol, M. Schwab, M. Schwartz, and M. G. Fehlings Spinal Cord Injury: Time to Move? J. Neurosci., October 31, 2007; 27(44): 11782 - 11792. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schori, R. Shechter, I. Shachar, and M. Schwartz Genetic Manipulation of CD74 in Mouse Strains of Different Backgrounds Can Result in Opposite Responses to Central Nervous System Injury J. Immunol., January 1, 2007; 178(1): 163 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Benner, R. L. Mosley, C. J. Destache, T. B. Lewis, V. Jackson-Lewis, S. Gorantla, C. Nemachek, S. R. Green, S. Przedborski, and H. E. Gendelman Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease PNAS, June 22, 2004; 101(25): 9435 - 9440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3374 - 3381. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |